-
EMA guidance for development of new antibiotics
EMA guidance for development of new antibiotics
-
EMA guidance for development of new antibiotics
EMA guidance for development of new antibiotics
EMA has published its revised guideline on the evaluation of human medicines against bacterial infections and an addendum related to antibiotics in children
-
CHMP highlights: May 2022
CHMP highlights: May 2022
-
CHMP highlights: May 2022
CHMP highlights: May 2022
EMA's human medicines committee (CHMP) recommended 9 new medicines for approval in the EU, including 3 medicines to treat rare genetic diseases at its May 2022 meeting
-
ICMRA-WHO statement on COVID-19 vaccine confidence
ICMRA-WHO statement on COVID-19 vaccine confidence
-
ICMRA-WHO statement on COVID-19 vaccine confidence
ICMRA-WHO statement on COVID-19 vaccine confidence
The International Coalition of Medicines Regulatory Authorities (ICMRA) and WHO issued a statement to support healthcare professionals to enhance public confidence in COVID-19 vaccines
-
Monthly safety update for COVID-19 vaccines
Monthly safety update for COVID-19 vaccines
-
Monthly safety update for COVID-19 vaccines
Monthly safety update for COVID-19 vaccines
EMA has released its latest safety update report on all COVID-19 vaccines authorised in the EU. It provides an overview of the safety monitoring of these vaccines
Information for you
Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal